PINNA, ANNALISA
 Distribuzione geografica
Continente #
EU - Europa 214
NA - Nord America 141
AS - Asia 17
AF - Africa 2
Totale 374
Nazione #
IT - Italia 203
US - Stati Uniti d'America 139
CN - Cina 5
KR - Corea 4
VN - Vietnam 4
FI - Finlandia 3
CA - Canada 2
CZ - Repubblica Ceca 2
RU - Federazione Russa 2
CG - Congo 1
GB - Regno Unito 1
GR - Grecia 1
IL - Israele 1
IN - India 1
JP - Giappone 1
NL - Olanda 1
PK - Pakistan 1
SE - Svezia 1
ZA - Sudafrica 1
Totale 374
Città #
Cagliari 175
Fairfield 16
Santa Cruz 16
Woodbridge 11
Buffalo 9
Ashburn 8
Houston 8
Seattle 8
Ann Arbor 5
Wilmington 5
Decimomannu 4
Dong Ket 4
Wuhan 4
Henderson 3
Las Vegas 3
Sassari 3
Bastia umbra 2
Brooklyn 2
Cambridge 2
Helsinki 2
Herndon 2
Los Angeles 2
Mountain View 2
Provo 2
Riva 2
Rome 2
Saint Petersburg 2
Athens 1
Beijing 1
Berkeley 1
Brazzaville 1
Contursi 1
Council Bluffs 1
Forlì 1
Genova 1
Hiroshima 1
Iglesias 1
Lahore 1
Lincolnshire 1
Messina 1
Milan 1
Milpitas 1
Modi‘in Makkabbim Re‘ut 1
Ottawa 1
Palo Alto 1
Phoenix 1
Potenza 1
Québec 1
San Diego 1
Sant'antioco 1
Selargius 1
Silverton 1
Udine 1
University Park 1
Totale 331
Nome #
Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease, file e2f56ed5-36af-3eaf-e053-3a05fe0a5d97 156
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice, file e2f56ed3-9fd0-3eaf-e053-3a05fe0a5d97 151
Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway, file e2f56ed7-8b00-3eaf-e053-3a05fe0a5d97 11
Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease, file e2f56ed4-5a54-3eaf-e053-3a05fe0a5d97 7
Influence of Age and Genetic Background on Ethanol Intake and Behavioral Response Following Ethanol Consumption and During Abstinence in a Model of Alcohol Abuse, file e2f56eda-d053-3eaf-e053-3a05fe0a5d97 7
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward, file e2f56ed4-5470-3eaf-e053-3a05fe0a5d97 6
Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l-DOPA-induced rotational behavior in a rodent model of Parkinson's disease, file e2f56ed4-57a0-3eaf-e053-3a05fe0a5d97 6
Characterization of Nasco grape pomace-loaded nutriosomes and their neuroprotective effects in the MPTP mouse model of Parkinson’s disease, file d54026a6-c169-45a5-a141-d6e485e3e3ab 5
L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies, file e2f56ed4-53e8-3eaf-e053-3a05fe0a5d97 4
Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists, file e2f56ed4-58f3-3eaf-e053-3a05fe0a5d97 4
Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration, file e2f56ed3-890e-3eaf-e053-3a05fe0a5d97 3
Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat, file e2f56ed4-5a57-3eaf-e053-3a05fe0a5d97 3
Role of adenosine A2A receptors in motor control: relevance to Parkinson’s disease and dyskinesia, file e2f56ed7-bf0b-3eaf-e053-3a05fe0a5d97 3
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug, file e2f56ed4-54e8-3eaf-e053-3a05fe0a5d97 2
A critical evaluation of behavioral rodent models of motor impairment used for screening of antiparkinsonian activity: The case of adenosine A2A receptor antagonists, file e2f56ed4-554c-3eaf-e053-3a05fe0a5d97 2
Adenosine A2A receptor antagonists and Parkinson’s disease: state of the art and future directions, file e2f56ed4-5a5b-3eaf-e053-3a05fe0a5d97 2
Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson’s Disease, file e2f56ed4-64e6-3eaf-e053-3a05fe0a5d97 2
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease, file e2f56ed5-122f-3eaf-e053-3a05fe0a5d97 2
Protective Agents in Parkinson’s Disease: Caffeine and Adenosine A2A Receptor Antagonists, file e2f56eda-8245-3eaf-e053-3a05fe0a5d97 2
Pharmacological therapy of Parkinson's disease: current options and new avenues, file e2f56ed4-5a49-3eaf-e053-3a05fe0a5d97 1
Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats, file e2f56ed4-5c23-3eaf-e053-3a05fe0a5d97 1
The Small GTP-Binding Protein Rhes Influences Nigrostriatal-Dependent Motor Behavior During Aging, file e2f56ed5-3691-3eaf-e053-3a05fe0a5d97 1
Totale 381
Categoria #
all - tutte 502
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 502


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20182 0000 00 00 0011
2018/201930 0203 11 01 2488
2019/202036 5314 32 33 5322
2020/202130 2223 24 11 1336
2021/202259 3342 75 43 33184
2022/202357 34148 63 172 0000
Totale 381